Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.

Pérez C, Mondéjar R, García-Díaz N, Cereceda L, León A, Montes S, Durán Vian C, Pérez Paredes MG, González-Morán A, Alegre de Miguel V, Sanz Anquela JM, Frias J, Limeres MA, González LM, Martín Dávila F, Beltrán M, Mollejo M, Méndez JR, González MA, González García J, López R, Gómez A, Izquierdo F, Ramos R, Camacho C, Rodriguez-Pinilla SM, Martínez N, Vaqué JP, Ortiz-Romero PL, Piris MA.

Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18098. [Epub ahead of print]

PMID:
31049933
2.

Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation.

García-Silva S, Benito-Martín A, Sánchez-Redondo S, Hernández-Barranco A, Ximénez-Embún P, Nogués L, Mazariegos MS, Brinkmann K, López AA, Meyer L, Rodríguez C, García-Martín C, Boskovic J, Letón R, Montero C, Robledo M, Santambrogio L, Brady MS, Szumera-Ciećkiewicz A, Kalinowska I, Skog J, Noerholm M, Muñoz J, Ortiz-Romero PL, Ruano Y, Rodríguez-Peralto JL, Rutkowski P, Peinado H.

J Exp Med. 2019 May 6;216(5):1230. doi: 10.1084/jem.2018152204162019c. Epub 2019 Apr 22. No abstract available.

3.

Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation.

García-Silva S, Benito-Martín A, Sánchez-Redondo S, Hernández-Barranco A, Ximénez-Embún P, Nogués L, Mazariegos MS, Brinkmann K, Amor López A, Meyer L, Rodríguez C, García-Martín C, Boskovic J, Letón R, Montero C, Robledo M, Santambrogio L, Sue Brady M, Szumera-Ciećkiewicz A, Kalinowska I, Skog J, Noerholm M, Muñoz J, Ortiz-Romero PL, Ruano Y, Rodríguez-Peralto JL, Rutkowski P, Peinado H.

J Exp Med. 2019 May 6;216(5):1061-1070. doi: 10.1084/jem.20181522. Epub 2019 Apr 11. Erratum in: J Exp Med. 2019 Apr 22;:.

PMID:
30975894
4.

Psoriatic alopecia-like paradoxical reaction to certolizumab pegol.

Aragón-Miguel R, Calleja-Algarra A, Vico-Alonso C, Sánchez-Velázquez A, Garrido MC, Ortiz-Romero PL, Rivera-Díaz R.

Int J Dermatol. 2019 Jun;58(6):e118-e120. doi: 10.1111/ijd.14417. Epub 2019 Mar 1. No abstract available.

PMID:
30825196
5.

Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report.

Vico-Alonso C, Calleja-Algarra A, Aragón-Miguel R, Sánchez-Velázquez A, Velasco-Tamariz V, Ortiz-Romero PL, Monsálvez-Honrubia V.

Dermatol Ther. 2019 Mar;32(2):e12829. doi: 10.1111/dth.12829. Epub 2019 Feb 7.

PMID:
30659716
6.

The Circulating Transcriptome as a Source of Biomarkers for Melanoma.

Solé C, Tramonti D, Schramm M, Goicoechea I, Armesto M, Hernandez LI, Manterola L, Fernandez-Mercado M, Mujika K, Tuneu A, Jaka A, Tellaetxe M, Friedländer MR, Estivill X, Piazza P, Ortiz-Romero PL, Middleton MR, Lawrie CH.

Cancers (Basel). 2019 Jan 10;11(1). pii: E70. doi: 10.3390/cancers11010070.

7.

Apremilast as a new treatment option for Acrodermatitis continua of Hallopeau.

Calleja Algarra A, Aragón Miguel R, Velasco Tamariz V, Prieto Barrios M, Andrés Lencina JJ, Vico Alonso C, Ortiz Romero PL, Rivera Díaz R.

Australas J Dermatol. 2019 Aug;60(3):e237-e238. doi: 10.1111/ajd.12990. Epub 2019 Jan 8. No abstract available.

PMID:
30623424
8.

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.

Karras P, Riveiro-Falkenbach E, Cañón E, Tejedo C, Calvo TG, Martínez-Herranz R, Alonso-Curbelo D, Cifdaloz M, Perez-Guijarro E, Gómez-López G, Ximenez-Embun P, Muñoz J, Megias D, Olmeda D, Moscat J, Ortiz-Romero PL, Rodríguez-Peralto JL, Soengas MS.

Cancer Cell. 2019 Jan 14;35(1):46-63.e10. doi: 10.1016/j.ccell.2018.11.008. Epub 2018 Dec 20.

PMID:
30581152
9.

Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.

Cabello I, Alia P, Pintó X, Muniesa C, Fernandez-de-Misa R, Peñate Y, Morillo M, Perez-Farriols A, Estrach T, Izu R, Gallardo F, Román C, Cervigón I, Ortiz-Brugues A, Ortiz-Romero PL, Servitje O.

JAMA Dermatol. 2018 Dec 1;154(12):1424-1431. doi: 10.1001/jamadermatol.2018.3679.

PMID:
30422238
10.

Chromoblastomycosis: an autochthonous case of a tropical disease.

Calleja Algarra A, Prieto Barrios M, Manrique Multiozábal A, Alonso Moralejo R, Fradejas Villajos I, Pérez-Ayala A, López Medrano F, Rodríguez Peralto JL, Ortiz Romero PL, Zarco Olivo C.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e76-e78. doi: 10.1111/jdv.15221. Epub 2018 Sep 23. No abstract available.

PMID:
30161267
11.

Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.

López-Lerma I, Peñate Y, Gallardo F, Martí RM, Mitxelena J, Bielsa I, Velasco-Tamariz V, Yanguas-Bayona JI, Sánchez-Sambucety P, García-Patos V, Ortiz-Romero PL, Pujol RM, Estrach T.

J Am Acad Dermatol. 2018 Nov;79(5):892-898. doi: 10.1016/j.jaad.2018.05.1243. Epub 2018 Aug 17.

PMID:
30126736
12.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators.

Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

PMID:
30100375
13.

Injection-site reaction to ixekizumab histologically mimicking lupus tumidus: Report of two cases.

Prieto-Barrios M, Rodriguez-Peralto JL, Vico-Alonso C, Velasco-Tamariz V, Calleja-Algarra A, Ortiz-Romero PL, Rivera-Diaz R.

Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):610-613. doi: 10.4103/ijdvl.IJDVL_786_17. No abstract available.

14.

Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome.

Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Knobler R, Quaglino P, Vermeer M.

Eur J Cancer. 2018 Sep;101:278-280. doi: 10.1016/j.ejca.2018.06.013. Epub 2018 Jul 13. No abstract available.

PMID:
30017383
15.

Mycosis fungoides progression could be regulated by microRNAs.

Manso R, Martínez-Magunacelaya N, Eraña-Tomás I, Monsalvez V, Rodríguez-Peralto JL, Ortiz-Romero PL, Santonja C, Cristóbal I, Piris MA, Rodríguez-Pinilla SM.

PLoS One. 2018 Jun 12;13(6):e0198477. doi: 10.1371/journal.pone.0198477. eCollection 2018.

16.

Asymptomatic facial papules as a marker of genetic syndrome.

Calleja Algarra A, Velasco Tamariz V, Aragón Miguel R, Prieto Barrios M, Pinilla Martín B, Llamas Martín R, Ortiz Romero PL, Monsálvez Honrubia V.

Neth J Med. 2018 May;76(4):198. No abstract available.

17.

Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.

Andrés-Lencina JJ, Burillo-Martínez S, Aragón-Miguel R, Calleja-Algarra A, Rodríguez-Peralto JL, Ortiz-Romero PL, Gargallo-Moneva V.

Australas J Dermatol. 2018 Nov;59(4):e302-e304. doi: 10.1111/ajd.12836. Epub 2018 May 24. No abstract available.

PMID:
29797309
18.

PIK3CA-assoziiertes Überwuchsspektrum: gleichzeitiges Auftreten mehrerer Anomalien bei einem Patienten.

Tous-Romero F, Quesada-Espinosa JF, Sánchez-Calvín MT, Ortiz-Romero PL, Palencia-Pérez S.

J Dtsch Dermatol Ges. 2018 May;16(5):603-605. doi: 10.1111/ddg.13487_g. No abstract available.

PMID:
29750448
19.

Collagenase nanocapsules: An approach to fibrosis treatment.

Villegas MR, Baeza A, Usategui A, Ortiz-Romero PL, Pablos JL, Vallet-Regí M.

Acta Biomater. 2018 Jul 1;74:430-438. doi: 10.1016/j.actbio.2018.05.007. Epub 2018 May 4.

PMID:
29734007
20.

The First Year of the AEVD Primary Cutaneous Lymphoma Registry.

Peñate Y, Servitje O, Machan S, Fernández-de-Misa R, Estrach MT, Acebo E, Mitxelena J, Ramón MD, Flórez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Pérez A, Gónzalez-Romero N, Domínguez JD, Muniesa C, López Robles J, Combalia A, Yanguas I, Suh H, Polo-Rodríguez I, Bielsa I, Mateu A, Ferrer B, Descalzo MA, García-Doval I, Ortiz-Romero PL.

Actas Dermosifiliogr. 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19. English, Spanish.

PMID:
29680323
21.

PIK3CA-related overgrowth spectrum: concurrence of multiple anomalies in one patient.

Tous-Romero F, Quesada-Espinosa JF, Sánchez-Calvín MT, Ortiz-Romero PL, Palencia-Pérez S.

J Dtsch Dermatol Ges. 2018 May;16(5):603-605. doi: 10.1111/ddg.13487. Epub 2018 Mar 26. No abstract available.

PMID:
29578286
22.

Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.

Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Evison F, Knobler R, Quaglino P, Vermeer MH.

Eur J Cancer. 2018 Apr;93:47-56. doi: 10.1016/j.ejca.2018.01.076. Epub 2018 Feb 21. Review.

23.

Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.

Prieto-Barrios M, Llamas-Martin R, Velasco-Tamariz V, Calleja-Algarra A, Ruano Y, Ortiz-Romero PL, Rodriguez-Peralto JL.

Br J Dermatol. 2018 Nov;179(5):1163-1167. doi: 10.1111/bjd.16435. Epub 2018 May 9.

PMID:
29430633
24.

AraC-Ohren - durch Medikamente ausgelöst oder Manifestation einer neutrophilen Dermatose?

Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, Calleja-Algarra A, Aragon-Miguel R, Ortiz-Romero PL, Zarco-Olivo C, Rodriguez-Peralto JL.

J Dtsch Dermatol Ges. 2018 Feb;16(2):213-215. doi: 10.1111/ddg.13425_g. No abstract available.

PMID:
29418105
25.

Ara-C ears: an actual drug-induced reaction or a distinctive manifestation of a neutrophilic dermatosis?

Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, Calleja-Algarra A, Aragon-Miguel R, Ortiz-Romero PL, Zarco-Olivo C, Rodriguez-Peralto JL.

J Dtsch Dermatol Ges. 2018 Feb;16(2):214-216. doi: 10.1111/ddg.13425. No abstract available.

PMID:
29418096
26.

Aprepitant did not modify global disease activity in cutaneous T-cell lymphomas.

Maroñas-Jiménez L, Ortiz-Romero PL.

Br J Dermatol. 2018 May;178(5):1222-1223. doi: 10.1111/bjd.16374. Epub 2018 Mar 23. No abstract available.

PMID:
29352481
27.

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.

Cifdaloz M, Osterloh L, Graña O, Riveiro-Falkenbach E, Ximénez-Embún P, Muñoz J, Tejedo C, Calvo TG, Karras P, Olmeda D, Miñana B, Gómez-López G, Cañon E, Eyras E, Guo H, Kappes F, Ortiz-Romero PL, Rodríguez-Peralto JL, Megías D, Valcárcel J, Soengas MS.

Nat Commun. 2017 Dec 21;8(1):2249. doi: 10.1038/s41467-017-02353-y.

28.

Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.

Maroñas-Jiménez L, Estrach T, Gallardo F, Pérez A, Andrés Borja H, Servitje O, Pérez Gala S, Linares Barrio M, Jiménez Gallo D, Sanz-Bueno J, Lora D, Monsálvez V, Ortiz-Romero PL.

Br J Dermatol. 2018 Apr;178(4):e273-e274. doi: 10.1111/bjd.16128. Epub 2018 Feb 22. No abstract available.

PMID:
29150837
29.

First-line treatment in lymphomatoid papulosis: a retrospective multicentre study.

Fernández-de-Misa R, Hernández-Machín B, Servitje O, Valentí-Medina F, Maroñas-Jiménez L, Ortiz-Romero PL, Sánchez Schmidt J, Pujol RM, Gallardo F, Pau-Charles I, García Muret MP, Pérez Gala S, Román C, Cañueto J, Blanch Rius L, Izu R, Ortiz-Brugués A, Martí RM, Blanes M, Morillo M, Sánchez P, Peñate Y, Bastida J, Pérez Gil A, Lopez-Lerma I, Muniesa C, Estrach T.

Clin Exp Dermatol. 2018 Mar;43(2):137-143. doi: 10.1111/ced.13256. Epub 2017 Oct 10.

30.

Eruptive nevi in a patient with metastatic breast cancer.

Calleja-Algarra A, Aragón-Miguel R, Velasco-Tamariz V, Andrés-Lencina JJ, Prieto Barrios M, Maroñas Jiménez L, Ortiz Romero PL, Monsálvez Honrubia V.

Int J Dermatol. 2017 Dec;56(12):1508-1509. doi: 10.1111/ijd.13717. Epub 2017 Sep 27. No abstract available.

PMID:
28960262
31.

The intralesional interleukin-2 is an adequate palliative treatment in cutaneous metastases of melanoma.

Menis D, Monsalvez-Honrubia V, Maroñas-Jiménez L, Morales-Raya C, Ortiz-Romero PL.

G Ital Dermatol Venereol. 2017 Aug;152(4):400-401. doi: 10.23736/S0392-0488.16.05342-6. No abstract available.

PMID:
28621122
32.

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group.

Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.

PMID:
28600132
33.

Widespread biphasic amyloidosis related to ipilimumab treatment for metastatic melanoma.

Velasco-Tamariz V, Burillo-Martínez S, Prieto-Barrios M, Calleja-Algarra A, Rodríguez-Peralto JL, Ortiz-Romero PL.

Int J Dermatol. 2017 Sep;56(9):e189-e191. doi: 10.1111/ijd.13642. Epub 2017 May 12. No abstract available.

PMID:
28500627
34.

Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum.

Burillo-Martinez S, Morales-Raya C, Prieto-Barrios M, Rodriguez-Peralto JL, Ortiz-Romero PL.

JAMA Dermatol. 2017 Jul 1;153(7):721-722. doi: 10.1001/jamadermatol.2017.0581. No abstract available.

PMID:
28467548
35.

Condyloma-like lesions in a young woman: Not always synonym of genital warts.

Aragón-Miguel R, Andrés-Lencina JJ, Calleja-Algarra A, Tous-Romero F, Ortiz-Romero PL, Guerra-Tapia A, Maroñas-Jiménez L.

Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:142-143. doi: 10.1016/j.ejogrb.2017.04.017. Epub 2017 Apr 8. No abstract available.

PMID:
28427733
36.

Leonine Facies, Flushing, and Systemic Symptoms.

Prieto-Barrios M, Ortiz-Romero PL, Rodriguez-Peralto JL.

JAMA Dermatol. 2017 Sep 1;153(9):925-926. doi: 10.1001/jamadermatol.2017.0746. No abstract available.

PMID:
28423166
37.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

38.

AEDV Primary Cutaneous Lymphoma Registry.

Estrach T, Servitje O, Ortiz-Romero PL.

Actas Dermosifiliogr. 2017 Apr;108(3):181-183. doi: 10.1016/j.ad.2017.02.008. English, Spanish. No abstract available.

PMID:
28347423
39.

Alternaria infectoria skin infection in a renal transplant recipient: an emerging phaeohyphomycosis of occidental countries?

Aragón-Miguel R, Calleja-Algarra A, Morales-Raya C, López-Medrano F, Pérez-Ayala A, Rodríguez-Peralto JL, Ortiz-Romero PL, Maroñas-Jiménez L.

Int J Dermatol. 2017 Jul;56(7):e153-e155. doi: 10.1111/ijd.13563. Epub 2017 Feb 27. Review. No abstract available.

PMID:
28244068
40.

Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.

Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, Zarco-Olivo C, Rodriguez-Peralto JL, Ortiz-Romero PL.

Br J Dermatol. 2018 Mar;178(3):786-789. doi: 10.1111/bjd.15400. Epub 2017 Oct 1.

PMID:
28222222
41.

DEK oncogene is overexpressed during melanoma progression.

Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestín C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL.

Pigment Cell Melanoma Res. 2017 Mar;30(2):194-202. doi: 10.1111/pcmr.12563. Epub 2017 Mar 7.

PMID:
27893188
42.

Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.

Pérez-Guijarro E, Karras P, Cifdaloz M, Martínez-Herranz R, Cañón E, Graña O, Horcajada-Reales C, Alonso-Curbelo D, Calvo TG, Gómez-López G, Bellora N, Riveiro-Falkenbach E, Ortiz-Romero PL, Rodríguez-Peralto JL, Maestre L, Roncador G, de Agustín Asensio JC, Goding CR, Eyras E, Megías D, Méndez R, Soengas MS.

Nat Commun. 2016 Nov 18;7:13418. doi: 10.1038/ncomms13418.

43.

Micosis fungoide e inhibidores del TNFα: ¿riesgo o beneficio?

Maroñas-Jiménez L, Burillo-Martínez S, Tous-Romero F, Rodríguez-Peralto JL, Ortiz de Frutos J, Ortiz-Romero PL.

Dermatol Online J. 2016 May 15;22(5). pii: 13030/qt5h25d0xs.

PMID:
27617528
44.

Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas.

Ortiz-Romero PL.

Br J Dermatol. 2016 Aug;175(2):246-7. doi: 10.1111/bjd.14783. No abstract available.

PMID:
27535600
45.

The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.

Sanz-Bueno J, Lora D, Monsálvez V, Maroñas-Jiménez L, Postigo C, Rodríguez-Peralto JL, Ortiz-Romero PL.

Br J Dermatol. 2016 Oct;175(4):794-6. doi: 10.1111/bjd.14559. Epub 2016 Jun 20. No abstract available.

PMID:
26990536
46.

[Primary anetoderma: A cutaneous marker of prothrombotic states].

Morales-Raya C, Maroñas-Jiménez L, Burillo-Martínez S, Ortiz-Romero PL.

Med Clin (Barc). 2016 Oct 21;147(8):e47. doi: 10.1016/j.medcli.2016.01.007. Epub 2016 Mar 5. Spanish. No abstract available.

PMID:
26961402
47.

Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome.

Child F, Ortiz-Romero PL, Alvarez R, Bagot M, Stadler R, Weichenthal M, Alves R, Quaglino P, Beylot-Barry M, Cowan R, Geskin LJ, Pérez-Ferriols A, Hellemans P, Elsayed Y, Phelps C, Forslund A, Kamida M, Zinzani PL.

Br J Dermatol. 2016 Jul;175(1):80-8. doi: 10.1111/bjd.14427. Epub 2016 Jun 2.

PMID:
26836950
48.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

49.

Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors.

Riveiro-Falkenbach E, Villanueva CA, Garrido MC, Ruano Y, García-Martín RM, Godoy E, Ortiz-Romero PL, Ríos-Martín JJ, Santos-Briz A, Rodríguez-Peralto JL.

J Invest Dermatol. 2015 Dec;135(12):3078-3085. doi: 10.1038/jid.2015.229. Epub 2015 Jun 17.

50.

[Eczematous lesions and acquired ichthyosis as a presenting finding of CD30+ anaplastic large cell lymphoma].

Sanz-Motilva V, Castellanos-González M, Martínez Sánchez P, Ortiz de Frutos J, Ortiz-Romero PL, Rodríguez-Peralto JL, Vanaclocha-Sebastián F.

Semergen. 2016 Apr;42(3):208-10. doi: 10.1016/j.semerg.2015.02.010. Epub 2015 Mar 25. Spanish. No abstract available.

PMID:
25817852

Supplemental Content

Loading ...
Support Center